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ABSTRACT
The progress made in plant biotechnology has provided an opportunity to new food
crops being developed having desirable traits for improving crop yield, reducing the
use of agrochemicals and adding nutritional properties to staple crops. However,
genetically modified (GM) crops have become a subject of intense debate in which
opponents argue that GM crops represent a threat to individual freedom, the
environment, public health and traditional economies. Despite the advances in food
crop agriculture, the current world situation is still characterised by massive hunger
and chronic malnutrition, representing a major public health problem. Biofortified
GM crops have been considered an important and complementary strategy for
delivering naturally-fortified staple foods to malnourished populations. Expert advice
and public concern have led to designing strategies for assessing the potential risks
involved in cultivating and consuming GM crops. The present critical review was
aimed at expressing some conflicting points of view about the potential risks of GM
crops for public health. It was concluded that GM food crops are no more risky than
those genetically modified by conventional methods and that these GM crops might
contribute towards reducing the amount of malnourished people around the world.
However, all this needs to be complemented by effective political action aimed at
increasing the income of people living below the poverty-line.
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RESUMEN
El progreso de la biotecnología de plantas ha hecho posible ofrecer una oportunidad
para desarrollar nuevos cultivos alimenticios con características deseables para el me-
joramiento de la producción, la reducción del uso de agroquímicos y la incorporación
de propiedades nutricionales en cultivos básicos. No obstante, los cultivos GM se han
convertido en un objeto de intenso debate, en el cual los opositores argumentan que
los cultivos GM representan una amenaza para la libertad individual, el medio am-
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biente, la salud pública y las economías tradicionales. A pesar de los avances en la
agricultura de los cultivos alimenticios, la situación actual a nivel mundial está carac-
terizada por una hambruna masiva y por una desnutrición crónica, lo cual constituye
un importante problema de salud pública. Los cultivos GM biofortificados se han
considerado como una estrategia importante y complementaria para suministrar
alimentos básicos naturalmente fortificados a las poblaciones con desnutrición. Las
recomendaciones de los expertos y las preocupaciones públicas han conducido al
diseño de estrategias para la evaluación de los riesgos potenciales de la producción y
el consumo de los cultivos GM. El objetivo de la presente revisión crítica es la exposi-
ción de algunos puntos de vista en conflicto sobre los riesgos potenciales de los cul-
tivos GM para la salud pública. Se concluye que los cultivos alimenticios GM no son
más riesgosos que aquellos modificados genéticamente con los métodos convencio-
nales, y que estos cultivos GM podrían contribuir a la reducción de la población con
desnutrición en el mundo, pero se necesita que esto sea complementado con acciones
políticas efectivas dirigidas a incrementar los ingresos de la población que vive por
debajo de la línea de pobreza.
Palabras clave: alimentos genéticamente modificados, biofortificación, evaluación de
riesgos, salud pública. 
INTRODUCTION
Farmers have successfully resorted to genetically improving their crops through
deliberated plant breeding for thousands of years, although its scientific basis was not
established until classical Mendelian genetics were rediscovered in the early twentieth
century (Robinson, 1999; Uzogara, 2000). Such classical or conventional technology
has been the major contributor towards maintaining food supplies during post-World
War II decades, noticeably increasing crop yields, particularly seen in intensive
agriculture of developed countries. For millennia, the traditional plant breeding
practices of farmers have led to altering the genetic constitution and evolution of crops.
In this sense, farmers have been considered to be the first genetic engineers (Jones,
1994; Prakash, 2001). The earliest evidence of agricultural practices dates from 10
thousand years ago in the part of the world now known as Iraq (Heiser, 1990). 
Research concerning the molecular and genetic mechanisms underlying important
agronomic traits has provided strong support for crop biotechnology in recent years.
Advances accumulated in molecular and cell biology during the last three to four
decades have revolutionised modern genetic improvement of crop cultivars.
Recombinant DNA technology, DNA sequencing from genes, using DNA markers for
constructing genetic maps, designing PCR-based methods for selecting and
characterising genes, and DNA transfer technologies between different species have
all laid the foundations for the modern production of the genetically-engineered
plants and crops currently on the market (Conner & Jacobs, 1999).
The biotechnology industry (mainly based in developed countries) has rapidly developed
food and agricultural products, besides other products in the fields of human health,
industrial processing and bioremediation. Livestock resulting from biotechnology was
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first reported over 30 years ago in the form of animal clones and later on as transgenic
animals. Genetically modified (GM) animals have been produced to improve animal
health, increase zootechnic performance, reduce the environmental impact of animal
production or produce biopharmaceutical products. None of them has entered the
market as food or fibre; however, livestock products from biotechnology are now
challenging science, regulators and the public to move into food and fibre markets
(Rexroad et al., 2007; Kochhar & Evans, 2007).
Although the benefits of transgenic technology are potentially enormous, scientists,
commerce, politicians, trade protectionists, environmentalists, religious rights’ groups,
consumers and the media are still involved in fierce debate about using this particular
kind of agricultural biotechnology (Acosta, 2002; Margulis, 2006). Many potentially
beneficial traits may be introduced into GM crops, such as enhanced pest- and disease-
resistance and herbicide tolerance, reduced fertiliser and water requirements,
enhanced nutritional value, extended shelf-life, improved flavour, modified aesthetic
and ornamental characteristics, the elimination of naturally-expressed toxins and
allergens, bioremediation and the production of pharmaceuticals (bio-factories)
(Fischer & Emans, 2000; Singh et al., 2006; Taylor et al., 2006). This paper provides an
overview concerning the debate regarding the safety of GM food crops. The material
presented leads to the conclusion that the process used in producing GM food crops
and current sound-science based methods used in assessing their safety make them no
more risky for the public health than conventionally-bred crop varieties.
THE DEBATE
Intense debate concerning GM crops has been prolonged in different sceneries during
the last couple of decades, involving a wide variety of actors. It should be stressed that
this debate be informed by sound-scientific data, information and knowledge to
contribute to a productive GM crop debate; however, philosophical points of view are
as important as scientific ones in such debate (Thro, 2004). Philosophical issues and
value judgments have been recently addressed and discussed regarding the claim that
environmental risks concerning GM and conventional crops are comparable on
scientific grounds (Thompson, 2003). These value judgments (present in part of the
discussion) incorporate assumptions associated with political, economic and ethical
issues which would not be easily resolved by scientific experimentation. Even the
politics of food safety (a very controversial field) incorporates philosophical problems
associated with the way scientific and policy issues should interact (i.e. there is
discussion about how food safety policy-making should be scientifically and
democratically legitimated; Millstone, 2007). 
Groups opposing GM crops have presumed that conventional crops do not represent
risks for the environment and food safety and, as such, new crop varieties produced
by conventional methods are not controlled by a regulatory environmental system. On
the contrary, transgenic crops have been associated with negative and harmful effects
on the environment and human health, no matter whether science-based evidence has
been available or not. Those arguing for the comparability of environmental risks of
GM and conventional crops have assumed that crops which have been genetically
modified by either transgenic technology or conventional methods are similar in terms
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of risks, traits and purposes (Thompson, 2003). In fact, transgenes incorporated into
transgenic crops have produced traits which are essentially the same as those desirable
agronomic traits which have been targeted by conventional breeding programmes.
Crop development thereby becomes a continuous process of introducing novel traits
where transgenic technology is a new stage following and coexisting with conventional
crossbreeding. Assessment policy regarding environmental risks is thus being based on
the product rather than the process (Brill, 1985; Brill, 1986).
The fears of the people opposing the technology producing GM crops are associated
with a wider spectrum of issues (Uzogara, 2000; Prakash, 2001; Pengue, 2004; Singh
et al., 2006) including the feeling that transnational companies are more interested in
increasing their profits than in protecting the environment or alleviating hunger, the
possibility that transgenic crops may invade wild ecosystems with detrimental effects on
biodiversity, the unfair competition with other agricultural systems such as organic,
agro-ecological and traditional ones, the negative effects that GM food might produce
on human health, the possible negative impact of GM crops on food supply safety, and
a lack of trust in the agencies responsible for regulating GM crop biosafety. Critics of
GM crops argue that transgenic technology has serious implications for farmers in
developing countries as this foreign multinational technology may destroy farmers’
competencies built around indigenous agricultural systems, thereby exacerbating social
exclusion in the case of subsistence farmers (Hall et al., 2008). They also warn that
multinationals do not take into account that transgenic technology might have broad
social and ethical implications. Controversy concerning GM crops also involves issues
related to the globalisation of agro-food systems and its effects on food safety, social
equity and rural agricultural systems (McAfee, 2008). In some countries (such as
Mexico) this dispute has been extended to include regional economic integration which
has been considered to implicate asymmetric and disadvantageous power relationships
in opening up markets around the world. However, most public concerns about GM
food crop safety are generally related to human health, consumer choice and
environment (Uzogara, 2000; Singh et al., 2006; Moyer & Anway, 2007).
Allegations regarding potential environmental harm have been based on possible cross-
pollination of wild plants with GM pollen, killing beneficial insects and producing new
weeds which are resistant to current control. However, the US EPA has concluded that
the existent statutory and regulatory framework has suitably addressed environmental
concerns raised by GM crops; the US FDA has recognised that food produced by
transgenic technology is safe and, therefore, has considered that labelling this kind of
food is not necessarily required (Moyer & Anway, 2007). US policy concerning GM
crops (as opposed to that of the European Commission) states that GM crops should
be allowed to prosper in the absence of scientifically-proven hazards. The debate also
includes the use made by the USA of modern genetic engineering to achieve its goals in
the plant-based bioeconomy, where plants are seen to be a source of fuel, energy and
other industrial chemical precursors, besides traditional uses of agricultural crops for
food, animal feed and fibres (Chapotin & Wolt, 2007).
Some non-GM movements have seemed to express their desire to change market
structures and capitalism as a whole. Nevertheless, their tactics against transgenic
crops and foods often strengthen and reproduce the very structures they are trying to
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change rather than promoting sustainable agriculture. Roff, 2007, has advanced an
interesting analysis of such contradictory behaviour by antibiotech activists; according
to this analysis, many antibiotech groups have been promoting neoliberal logic as they
have focused on the contemporary markets as the best way of ensuring alternative
agriculture. Their tactics remain focused on what can be done at the commodity level.
There is emergent discourse regarding individualism and consumer freedom as a means
to interfere the practices of food manufacturers. This means that the more you buy the
more pressure is placed on manufactures to change their practices. As a result, market-
based activism provides a space for rent-seeking practices of food manufactures. Roff,
2007, emphasises that consumerism does not guarantee alternative sociologies,
economies and agriculture espoused by current food movements.
Although the non-GM movement criticises the state to some extent, the most
common tactics encourage consumers to act through their money in buying non-GM
foods; this therefore indicates that desired changes come primarily from the market
rather than the legislature. Neoliberalisation of antibiotech activism is transferring
state and food manufacture responsibility to individual consumers; neoliberalising
logic thus states that non-GM activism empowers the market rather than the state.
The market thus becomes the final judge of social and environmental quality,
reinforcing the ideology of competitive advantage and free market rationality (Roff,
2007). The state and manufactures are thus not responsible for food quality as they
only respond to what consumers want (Roff, 2007).
Despite fierce opposition to GM crops (or partly as a consequence of such opposition),
several countries have managed to develop science-based biosafety regulatory systems.
Scientific bodies have recently proposed guidelines for assessing the nutritional value and
safety of GM crop-derived feed and food (OECD, 2003; ILSI, 2003; 2004; EFSA, 2004);
there is also a regulatory framework for GM crops and food encompassing principles of
risk analysis, institutions, policy, laws and guidelines (Konig et al., 2004). Effective risk
assessment and monitoring mechanisms are essential prerequisites for any regulatory
framework to properly address the potential risks of GM crops (Singh, et al., 2006).
Regulations and restrictions on GM crops have been considered as obstacles which
must be reduced to allow the world’s population to take complete advantage of what
such technology is offering (Potrykus, 2001; Pawlak, 2005). Some have concluded
that unnecessary restrictions and regulations are still in force, partially due to
demands from anti-genetically modified organism (GMO) organisations, such as
Greenpeace, 2005, or they have been strongly influenced by consumer perceptions
(Kleter et al., 2001). Anti-GMO campaigns against poor and malnourished people
using GM crops and food (even when multinational companies do not benefit) might
be seen to be inconsistent with the interests of those whom non-GM activism tries to
fight for (Potrykus, 2001). It should be stressed that the remarkable public debate
and sound-scientific discussion on the safety of GM crops has resulted in introducing
compulsory risk assessment of these crops; some accurate molecular tools have been
produced for use in large-scale screening of GM crops as part of such assessment
protocols (Made et al., 2006; Jeong et al., 2007). However, non-scientific criticism of
GM crops will doubtless delay productivity-enhancing biotechnology applications
being developed in less developed economies. 
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Although GM crops have been subjected to intense controversy they are now grown in a
number of countries in which more than half the world’s population lives. Ten years after
the commercial introduction of GM crops their world-wide area had reached more than
102 million hectares (252 million acres) by 2006 and the number of farmers growing
these crops had exceeded 100 million (ISAAA, 2006; Brookes & Barfoot, 2006). It seems
to be that the obvious advantages of transgenic technology for improving agronomic
performance and yield of crops have encouraged extensive GM crop growing. GM crops
have therefore been the most rapidly adopted technology in the history of agriculture
(Halpin, 2005). Although the USA is the leading country in transgenic technology research
and development, more than half the 63 countries engaged in biotech research belong to
the developing world (Acosta, 2000; Newell-McGloughlin, 2006), China being foreseen
as the future leader in GM crops (Oliver & Hankins, 2007).
FOOD AND THE GLOBAL POPULATION
The world’s population exceeded the 6 billion mark at the end of the twentieth century.
This means that the global population more than doubled during the second half of the
twentieth century. It has been predicted that the planet will have around 7.5 billion
people on it by 2020, rising to 9 to 10 billion by 2050. Most of this growth is supposed
to occur in poor countries, where 80% of the world’s population is currently living. It has
been estimated that demand placed on world agricultural production by 2050 will
double, assuming moderately high income growth taken together with expected
population growth (Johnson, 2000; United Nations, 2001; Ruttan, 2002).
However, rigorous investigation must be carried out within the context of producing
enough food to feed the world to establish the relative contributions of all forms of
available agriculture, including transgenic crops, organic agriculture, agroecology and
other forms of traditional agriculture (Lacey, 2002). Some authors have anticipated that
the supply of organic products will not be able to meet future demand, which would lead
to such shortfall being filled by conventional non-GM crops at a cheaper price (Roff,
2007). This means that if the organic alternative is taken, then the increasing demand
for large acreage crops would cause the weakening of conventional crops’ quality stan-
dards (Roff, 2007). Although transgenic technology could contribute towards resolving
crop deficiencies, it does not mean that all agriculture should become transgenic. 
Resolving the low productivity, poverty and difficulties which resource-poor farmers
are facing (mainly in developing countries) would require several strategies and
policies. Hunger and poverty in developing countries may not be resolved simply by
increasing world food production and productivity. In fact, today’s world food
production is greater than that required to feed all the people living on the earth, but
there are more hungry people in the underdeveloped world today than there were in
1996. The number of undernourished people was estimated to be 820 million in 2003
and it has been increasing since then at the rate of four million per year (FAO, 2004).
Although poverty in terms of household income has fallen worldwide since 1990
(except in sub-Saharan Africa) 2.8 billion people are currently living on less than two
dollars a day and 1.3 billion are living in a situation of even more extreme poverty,
surviving on the equivalent of less than one dollar a day; this means that about
half the world’s population is trying to survive below the poverty threshold of two
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dollars a day (UNDP, 2006). Developing countries’ hunger and poverty thus also involve
environmental, demographic, social, economic, political and cultural factors which
need to be addressed and resolved. Institutional factors are as important as transgenic
technology performance (Raney & Pingali, 2007). Transgenic technology potential for
providing enough, safe and effective food to alleviate hunger needs to be complemented
with effective political action aimed at pursuing the moral obligation of providing the
hungry with sufficient nourishment (Carter, 2007).
Some information indicates that per capita cereal grain production has been declining
since 1984 due to rapid population growth and the per capita decline of cropland,
irrigation and the use of fertilisers (Pimentel et al., 2000). Increased food production to
satisfy a growing world population should not be done at the expense of incorporating
new land for agricultural purposes. Without disregarding some potential crop-
producing land, an increase in food must come mainly from increasing the productivity
of land currently being cultivated. Those countries at the technological frontier (which
have reached their highest performance in terms of agricultural productivity) will thus
probably have little difficulty in accomplishing the production levels needed to satisfy
their slowly rising demand for food (Ruttan, 2002). On the other hand, advances in
transgenic technology for countries which are far from approaching the scientific and
technological frontiers of agricultural productivity could represent an opportunity for
improving their rate of crop productivity. Pre- and post-harvest crop losses in tropical
and subtropical developing countries caused by pests, disease, low quality soil and poor
storage facilities are exacerbated by climatic conditions and a lack of economic resources
for purchasing improved seed, fertilisers and insecticides. GM crops are therefore seen
to be very promising in increasing agricultural productivity in developing countries,
where transgenic technology can be applied to different crops without implying major
changes in subsistence farmers’ agricultural practices (Herrera-Estrella, 2000).
BIOFORTIFICATION
Improving food crops to provide better nutrition for humans and livestock has been a
major long-term aim of traditional breeding programmes. Biofortification (an approach
consisting of bred food crops producing high bio-available nutrient concentrations in
some of their edible tissues) has been presented as a promising alternative for fighting
malnutrition in poor countries. Iron, vitamin A, zinc and iodine deficiencies are of the
greatest public health importance as they represent a serious threat to the health and
productivity of more than one-half of the world’s population, women and children being
most exposed to such micronutrient deficiencies (Darnton-Hill, 1998; United Nations,
2004). Vitamin A deficiency (VAD) is one of the leading causes of micronutrient
malnutrition in less industrialised countries, annually causing about half a million
children to become partially or totally blind (Conway & Toenniessen, 1999; West, 2002)
and claiming 3,000 lives every day (Raney & Pingali, 2007). The World Health
Organisation (WHO, 1995) estimated that 254 million children were vitamin A
deficient in 1995 and around 2.8 million children aged less than five were afflicted
by xerophthalmia, a severe manifestation of VAD. A more recent study has indicated
that around 127 million and 4.4 million preschool children were suffering from VAD
and xerophthalmia, respectively (West, 2002). The study also found more than 7.2
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million pregnant women affected with VAD in developing countries and another 13.5
million with low vitamin A status. About 45% of the children affected by VAD and
xerophthalmia and the pregnant women having low or deficient vitamin A live in South
and Southeast Asia (West, 2002) where rice is a staple crop.
Micronutrient intervention by fortifying staple foods has been found to be a major
factor in reducing micronutrient deficiencies in developed countries (Darnton-Hill &
Truswell, 1990; Nestel, 1993; Bower, 1996; Darnton-Hill, 1998) and, although fortifi-
cation programmes have recently been successfully implemented in Latin-American
countries (Darnton-Hill, 1998), both previous and recent experience in other developing
countries has suggested that fortification programmes are not always suitable for such
countries (Murphy, 1996; Darnton-Hill, 1998; Mayer, 2005). National governments and
authorities are facing problems in deploying and maintaining efficient supplement and
fortification programmes. The factors constraining developing fortification programmes
have been classified as being technical, socio-economic, infrastructural and political
(Darnton-Hill, 1998). Although breeding-based solutions to micronutrient deficiencies
initially need substantial investment for their development, micronutrient-improved
varieties can be grown and consumed during the years ahead without incurring greater
additional cost (Nestel et al., 2006). Even though this approach is cost-effective,
conventional breeding methods have been unsuccessful in producing staple crops having
high vitamin A content. Transgenic technology has recently been used for producing GM
rice that produce high pro-vitamin A concentration, this being an example of direct
benefit to the consumer by increasing micronutrient content in the crop edible parts.
Staple mineral- and vitamin- dense foods represent a low-cost, sustainable strategy for
reducing the percentage of micronutrient malnutrition.
Golden Rice, a variety of rice engineered to produce β-carotene (pro-vitamin A), has
been further improved to produce 23 times more total carotenoids than the previous
Golden Rice version produced in 2000 (Paine et al., 2005). Despite the potential of this
achievement as a viable and sustainable alternative contributing towards alleviating
VAD in many poor countries (Mayer, 2007) antibiotech opponents have claimed that
Golden Rice is not effective and superfluous (Greenpeace, 2005). Some Golden Rice
critics argue that this GM crop might actually interfere with current vitamin A
supplement and fortification programmes (Mayer, 2005); however, opponents of GM
technology often ignore the great number of people who are not receiving the benefits
of these programmes. It is well documented that even in countries having ongoing
supplement and fortification programmes (i.e. India) about 57% of children aged less
than six are affected by sub-clinical VAD (Mayer, 2005). On the contrary, economic
analysis of Golden Rice is based on anticipated profits of several billion US dollars for
South-eastern Asian countries (Anderson et al., 2004), whereas scientific data does
not predict any harmful effects for human beings or any deleterious consequences for
the environment (Lu & Snow, 2005).
Another example of directly improving food micronutrients comes from Iron Rice which
is a GM rice having increased iron content obtained by inserting a gene from the
Aspergillus niger fungus into the rice genome (Prakash, 1997; Lucca, 1999). This
transgene encodes phytase, an enzyme which degrades the phytate present in rice seed
endosperm; this enzyme releases and makes phosphorous, calcium and other mineral
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micronutrients available. A heat-stable form of Aspergillus fumigatus phytase has also
been engineered which can break down the phytate ingested from other food sources
(Prakash, 1997). Transgenic soybean production has been also described, expressing
phytase through inserting a liner construct lacking selectable markers and other vector
sequences (Gao et al., 2007); phytase activity has thus been increased 2.5 times,
compared to an untransformed plant. GM rice having increased iron concentration has
also been produced by transferring the soybean ferritin gene which encodes an iron-
binding protein (Goto et al., 1999). Iron deficiency causes anaemia in child-bearing
aged women and in young children. This condition makes pregnant women more
susceptible to stillborn, underweight children and to mortality at childbirth. According
to Conway & Toenniessen, 1999, anaemia has been found to be a factor accounting
for more than 20% of maternal deaths in Asia and Africa after mothers have given birth.
Pro-vitamin E availability in vegetable oils is relatively low, compared to potential
availability. Tocochromanols (tocotrienols and tocopherols) are lipophylllic antioxidants,
especially accumulating in oilseeds. Vitamin E is present in the form of tocotrienols and
tocopherols which have differential vitamin E activities. Most plant seeds have higher γ-
tocopherol content than α-tocopherol, the latter having ten times more vitamin E
activity than the former (Bramley et al., 2000; Schneider, 2005). Two Arabidopsis thaliana
genes encoding methyltransferases (VTE3 and VTE4) have been combined into the
soybean genome to increase soybean vitamin E activity. The seeds from the resultant
GM soybean exhibited more than 95% α-tocopherol content (Van Eenennaam et al.,
2003), corresponding to 8-fold pro-vitamin E content. A strategy has been reported
recently for engineering commercial oilseed thereby producing oils having highly
enhanced tocochromanols and vitamin E content (Karunanandaa et al., 2005). An F2-
seed was obtained from crossing transgenic high tocochromanol soybean with
transgenic high α-tocopherol soybean; this had vitamin E activity 11-times higher than
that of an average wild soybean. Biofortification of currently accepted food crops,
together with transgenic technology and conventional breeding, could offer a
sustainable alternative to malnutrition affecting many millions of people (mainly
children) around the world. Biofortification through GM crops represents a potential
complement to current supplement and fortification programmes and campaigns.
ASSESSING GM FOOD CROP SAFETY
Genetic engineering allows the transfer of known encoding or non-encoding DNA across
species thereby leading to intended genetic food crop modification. Such modifications
are more specific, controlled and rapid than those obtained via conventional breeding
and selection methods. However, inserting foreign genes into the plant genome could
also have unintended and unexpected pleiotropic effects on the host, leading to changes
in the expression level of some genes (and their corresponding proteins) which are
unrelated to the desired modification (Wal, 2001; Rischer & Oksman-Caldentey, 2006).
However, unintended modification of gene expression in food crops can occur in any
kind of traditional breeding; concerns about potentially unintended modifications
should not therefore be restricted to GM food crops (Bernstein et al., 2003).
Assessment strategies and guidelines related to the safety of GM crop-derived food
have been based on the principle of substantial equivalence which requires comparing
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the GM crop to an appropriate reference crop, usually the conventionally-bred parent
crop (OECD, 1993; Konig et al., 2004). The aim of GM crop safety assessment is
essentially to compare GM crop safety with that of conventionally-bred varieties. Such
comparison allows significant differences to be identified in terms of morphological and
agronomical characteristics and chemical composition. The conventional counterpart is
generally assumed to be safe, according to its history of human consumption. The food
safety standard for GM food crops is that these foods must be at least as safe as food
derived from conventional crops. GM crop-derived food is assessed by following some
steps including characterising the parent crop and any hazards related to it,
characterising the donor organism from which the transgene has been derived and the
transformation procedures, characterising transferred transgene products (protein
and metabolites) to establish their potential toxicity and allergenicity and identifying
any targeted or unintended change produced in the food or edible parts of the GM
crop (Konig et al., 2004; Hothorn & Oberdoerfer, 2006). 
So-called first generation GM crops (EFSA, 2004; ILSI, 2004) have been characterised
by input traits which are assumed to produce no substantial changes in their composi-
tion as compared to their isogenic counterparts within the framework of substantial
equivalence (OECD, 1993). These input traits have included tolerance to herbicides or
resistance to insects. On the other hand, so-called second generation GM crops (ILSI,
2004) have been genetically modified to express output traits such as greater concentra-
tion of amino acids, fatty acid, vitamins and lower allergen content or substances
making nutrients unavailable (Flachowsky & Bohme, 2005). These crops have received
increasing scientific support for preventing and treating disease (Newell-McGloughlin,
2006). The first generation GM crops engineered with input traits to provide improved
agronomic performance and economic and environmental benefits have been asso-
ciated with farmers’ interests. However, there is an increasing trend towards producing
second generation GM crops by transferring value-added output traits, mainly benefit-
ing consumers and processors. Promising markets for nutraceuticals (functional foods)
and bioreactors for producing valuable proteins, pharmaceutical products and other
compounds fall within this second generation of GM crops (Mascia & Flavell, 2004;
Newell-McGloughlin, 2006; Sardana et al., 2007; Stoop et al., 2007).
International panels of experts have considered that transgenic technology is not inher-
ently risky as all DNA is chemically and structurally the same (irrespective of its origin)
(Royal Society, 1998; Royal Society, 2002). Human beings (as thermodynamically open
and non-equilibrium systems) take energy and matter from the outer environment,
foreign DNA being part of food derived from living matter. The passage of food DNA
fragments across the intestinal wall is a natural and physiological phenomenon, mainly
when DNA is at high concentrations in the food. Transferring DNA between different
species has also been a major driving force in the evolution of living organisms. Given
that livestock consume substantial amounts of GM crop-derived plant feed, public
concern about the consumption of animal products containing transgenic DNA and
protein have led to investigations related to their fate within the gastrointestinal tract of
livestock and the possible accumulation of transgenes and their encoded proteins within
tissues. Transgenic protein has not been detected in any animal tissue or product when
using DNA- and protein-based assays (Alexander et al., 2007). On the other hand, small
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fragments of endogenous DNA from high-copy number chloroplast genes have been
detected in tissues from pigs, ruminants and poultry. Endogenous and transgenic DNA
fragments from low-copy genes have been detected in animal tissues, but in lesser
amounts than that detected in the case of high-copy genes. Passage of plant DNA frag-
ments, endogenous or not, across the intestinal barrier does not appear to have had
adverse effects on livestock (Alexander et al., 2007; Ramessar et al., 2007). It has been
estimated that the proportion of GM DNA content in typical livestock diets represents
about 0.00042% of total dietary DNA intake (Beever & Kemp, 2000), practically all of it
being hydrolysed to small fragments and ultimately converted into individual non-coding
monomers.
Proteins expressed by GM crops have raised some concern as they may be involved in
food allergies. Assessing allergenicity to GM foods and novel proteins has included
decision trees using clinical and laboratory methods leading to scientific evaluation
of the potential allergenic risks of GM crops prior to their sale (FAO/WHO, 2001;
Metcalfe, 2003; Acosta & Guerrero, 2007). One main approach has been to assess
whether an introduced protein has been encoded by a gene taken from a source known
to be allergenic. Transgenic technology uses well-characterised transgenes encoding
proteins which can be examined for their structural similarity and sequence homology
to known allergen amino acid sequences obtained from allergenic food proteins.
Serological assays have been conducted for detecting human specific IgE antibodies
against food allergens which can be made to react with a GM food crop to look for
allergens. It has thus been possible to detect a positive reaction between human IgE
and protein from transgenic soybean modified with a Brazil nut-derived gene (Nordlee
et al., 1996). As expected, this GM soybean was not marketed. Assessing allergenicity
to GM crops has also involved physicochemical and biochemical assays relating
protein stability to heat, acid and digestive enzymes. Moreover, transgenic technology
has been useful in producing hypoallergenic crops by interfering with the expression of
genes encoding major allergens (Bhalla & Singh, 2004; Acosta & Guerrero, 2007).
Genetic engineering has also enabled improving food and feed protein quality by
incorporating genes encoding non-allergenic proteins containing essential amino acids
(De Lumen, 1997; Roller & Hallander, 1998; Chakraborty et al., 2000).
StarLink corn produced by the Aventis Corporation was approved by the US EPA as
animal feed; however it was confirmed in 2000 that this GM crop had contaminated
human food. Many consumers reported allergic symptoms deriving from their contact
with StarLink following media coverage of this incident. This corn, containing Bt (Bacillus
thurigiensis) insecticide protein Cry9C, had not been approved for human consumption
due to the heat stability of this protein compared to other Bt proteins, suggesting that
the Cry9C protein might be an allergen for humans (Bucchini & Goldman, 2002). The
US FDA, US EPA and US Department of Agriculture Food Safety and Inspection Service
provided assistance for obtaining information about exposure to StarLink and its
potential adverse effects (Bernstein et al., 2003). After examining a group of patients
showing symptoms consistent with allergic reactions, the CDC (Centers for Disease
Control & Prevention) could not demonstrate that the Cry9C protein was indeed the
product responsible for the adverse health reaction. No IgE from patients was found to
be reactive with the Cry9C in protein ELISA tests (CDC, 2001).
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Plant transgenic technology commonly uses antibiotic and herbicide resistance selec-
table marker gene systems, thereby leading to GM plant production. Although there
is no justification in terms of safety, public perception about antibiotic resistance
selectable markers has partly promoted the search for marker-free transformation
systems. A recent review on the use of these selectable markers discussed the currently
available scientific literature in detail; this overwhelmingly supports the conclusion
that there is no scientific basis against the use and presence of antibiotic resistance
selectable marker genes in GM plants (Ramessar et al., 2007). Within the context of
using proteinase inhibitors, transgenic expression of cystatin (a cystein proteinase
inhibitor) confers partial resistance to plant nematodes. Cystatins occur naturally in
rice, maize, potato tubers, human saliva and egg-white. It has been concluded that an
engineered rice cystatin has no toxicity for humans arising from its expression in roots
(Atkinson et al., 2004).
A recent study of GM wheat could be illustrative of a scientific approach to the alleged
substantial equivalence of GM and non-GM crops (Shewry et al., 2007). A detailed
and systematic comparison of GM composition and performance with that of
conventional lines of wheat was conducted in field and glasshouse conditions. It was
concluded that transgene expression in the lines being studied was intrinsically as
stable as that of the corresponding endogenous genes; both GM and control lines
showed similar stability in agronomic performance. Gene expression and metabolite
profiles of GM and control lines also reinforced the idea that GM wheat can be
produced which is substantially equivalent to conventional wheat. This does not mean
that all GM crops are substantially equivalent to their conventional counterpart, and
the case by case protocol continues being valid.
More than 18 studies involving feed from GM crops used in nutrition for many farm
animals have been conducted since 1997. In a recent report, Flachowsky et al. (2007)
advanced results from studies on GM crop-derived feed which were in agreement with
more than 100 international experiments. They showed that GM crops had no
substantial changes made to their composition and they did not significantly differ in
their nutritional attributes from those of their isogenic counterparts. Moreover,
recombinant DNA was not found in any organ or tissue samples obtained from
animals fed with feed from first or second generation GM crops; a proposal was
submitted for nutritional assessment of second generation GM crops (Flachowsky &
Bohme, 2005; Flachowsky et al., 2007).
The safety of Roundup Ready corn (a glyphosate herbicide-tolerant GM corn) was
assessed in a 13-week study of feeding rats. Herbicide tolerance was produced by insert-
ing the transgene from Agrobacterium sp. strain CP4 which expresses the CP4 EPSPS
enzyme (5-enolpyruvylshikimate-3-phosphate synthase), which is not inhibited by glyphosate.
Comparison between rats fed diets containing the GM corn and control rats fed corn
grain from conventional varieties led to confirming that the Roundup Ready corn grains
were as safe and nutritious as conventional corn grain (Hammond et al., 2004).
Additional studies have shown the safety of CP4 EPSPS protein (Ramessar et al., 2007).
Bt Rice has been engineered to express cry genes providing resistance to major lepi-
dopteran insects affecting rice. Such genetic modification has the potential for reducing
chemical insecticide applications, decreasing yield loss and reducing mycotoxin levels
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which are a consequence of larval attacks (Papst et al., 2005). Bt rice KMD1 (expressing
Cry1Ab protein and exhibiting high levels of resistance to at least eight different insect
pest species) was submitted to a comparative 90-day safety assessment study in an
animal model (Wistar rats; Schrøder et al., 2007). No adverse or toxic effects were
observed during the study after comparing haematological and biochemical parameters
and examining a large number of organs. A few parameters were significantly different,
but remaining within the normal reference limits for rats of this kind and age. A gene
encoding Galanthus nivalis snowdrop lectin (GNA lectin) has been inserted into a number
of different food crops including rice, wheat, potatoes and sugarcane (Stoger et al.,
1999; Setamou et al., 2002; Poulsen et al., 2007) to confer resistance to several insect
pest species (Powell et al., 1998). A 90-day feeding study was conducted for comparing
the safety of a new GM rice variety expressing GNA to its parental variety (Poulsen et al.,
2007). The results of this study revealed several significant differences between rats fed
diets with GM and parental rice; they were probably related to GNA lectin content, but
none of the effects were considered to be adverse. However, the authors concluded that
the design of this 90-day study including one control group and one group given the GM
food was not enough for assessing the safety of this GM food crop.
GM crop-derived food ingredients are found in thousands of food products consumed
worldwide (Prakash, 2001). Science-based reasoning and accumulated research
regarding crop improvement have allowed the scientific community to support GM
crops. There is scientific confidence that GM crops do not represent greater risks than
those already present in conventional agriculture and that any new risk posed by GM
crops could be identified, managed and prevented (Prakash, 2001). In fact, GM crops
are subjected to rigorous testing within a regulatory framework developed for
supervising their commercialisation. Obviously, risks from GM crops must be
identified, measured and balanced against the enormous benefits that this technology
can offer to a growing world population.
There are specific regulations for the agronomic coexistence of GM crops and their
conventional relatives to prevent cross-fertilisation between GM and non-GM crops
during their production. Such regulations involve defining isolation distances which
may differ, depending on the scientific criteria defined for a particular agricultural
context (Tolstrup et al., 2003; Sanvido et al., 2008). 
RISKS INVOLVED IN CONVENTIONALLY-PRODUCED FOOD CROPS
GM crop critics commonly ignore the fact that conventionally bred varieties contain
proteins and metabolites which are eventually harmful for humans. Indeed, several
conventional crop varieties have been removed from the market due to the severe toxic
effects produced on humans. In the case of allergy to food, about 6-8% of children and
2-3% of the adult population present allergic reactions to food (Young et al., 1994;
Munoz-Furlong et al., 2004; Acosta & Guerrero, 2007). Most food allergies are induced
by peanuts, milk, eggs, tree nuts and fish and crustaceans, although more than 160
foods and food-related substances have been identified as allergic reaction inducers
(Metcalfe et al., 1996). All known food crop allergens are contained in conventionally
modified crops. By contrast to GM crops, conventional crops have  not been routinely
tested for toxic or allergic effects on consumers prior to their commercial release,
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disregarding that traditionally-bred food may contain natural toxins, anti-nutrients and
carcinogenic compounds.
Assessing the risk of GM plants using conventional methods has been essentially derived
from incidental records (Hodgson, 2001). It has been well-documented for a long time
that plants’ secondary metabolites can be toxic for humans and animals. Thus, any
genetic modification caused by transgenic or conventional breeding technology could be
seen to be a potential hazard in terms of concentration changes of these secondary
compounds. Without disregarding the case by case principle for risk assessment,
conventional varieties produced by traditional breeding seem to show a greater
probability of producing toxic effects on humans. For instance, toxic glycoalkaloids
are present in potatoes but their concentration in tubers from most varieties is not
harmful for humans (Friedman & McDonald, 1997). Nevertheless, there are a number
of reported cases of humans having been poisoned by the high glycoalkaloid content of
conventional potato varieties (Friedman & McDonald, 1997). For example, the Lenape
variety of potato developed by conventional Solanum tuberosum and S. chacoense breeding
was withdrawn from the market (Sinden & Webb, 1972) after its commercial release in
1967 (Akeley et al., 1968) due to illness caused by ingesting its tubers which contain high
glycoalkaloid levels (Zitnack & Johnson, 1970). A popular potato variety (Magnum
Bonum) was also withdrawn from the market in Sweden for similar reasons (Hellenas et
al., 1995). Glycoalkaloid aglycone proportions in potato have been shown to depend on
interspecific somatic hybrid genome constitution (Laurila et al., 2001; Laurila et al.,
2001a). New and possibly toxic glycoalkaloid aglycones can be produced in such
somatic hybrids, even though they have not been found in any of the parental lines.
These new compounds have apparently resulted from bringing together substrates and
enzymes which have not previously been in contact. For example, inter-specific somatic
hybrids between Solanum brevidens and S. tuberosum have been found to contain the toxic
steroidal alkaloid demissine. A hypothesis has been advanced that a hydrogenase present
in S. brevidens normally produces tomatidine from teinamine; however, in the new cellular
environment created by somatic hybridisation, this enzyme produces demissine from
solanidine, a substrate found in S. tuberosum but not in S. brevidens (Laurila et al., 1996).
Conventional plant breeding methods can lead to other unintended results. Celery
contains furanocoumarins which are mutagenic, carcinogenic and reproductive
toxicants, and can also cause contact dermatitis. A new celery variety was conventionally
developed and selected for its resistance to Fusarium, but the high content of linear
furanocoumarins causing severe contact dermatitis in field workers became apparent
when this variety was almost ready for commercial release (Trumble et al., 1990;
Diawara & Trumble, 1997). The cases referred to above show that conventional genetic
modification of crops might produce unexpected and unintended effects, although it
is well recognised that traditional plant breeding has contributed to agriculture by
producing many safe food crops and has also successfully removed toxic elements from
several foods (Uzogara, 2000). Prakash (2001) has stressed that solanine found in
tomatoes and potatoes can cause spina bifida and that phyto-hemagglutinin from
kidney beans is toxic. African cassava contains cyanogenic glucosides which can produce
limb paralysis when consumed before proper processing; peach seeds are also very rich
in cyanogenic glucosides. Many foods in our daily diet naturally contain thousands of
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compounds, many of them being carcinogenic or hazardous when tested at high doses
in lab animals. It has been reported that roasted coffee contains more than 1,000
different chemicals and that after testing 27 of them, 19 were found to be carcinogens
for rodents (Ames & Gold, 1997). None of these food crops, and many others, has been
subjected to mandatory testing for risk assessment.
Despite the risks associated with food derived from new varieties produced by
traditional plant breeding, these food products have been readily and widely accepted
as part of the human diet for many years. Any genetic manipulation by traditional plant
breeding or genetic engineering methods inherently has the potential risk of producing
new food hazards which can arise from the products encoded by the inserted
transgenes or the introgressed chromatin fragments from wild species into the new
cultivars. In both cases, the secondary pleiotropic effects leading to unintended
modifications of gene expression cannot be ruled out. Therefore, the risks associated
with inserting new genes through genetic engineering must be considered within the
same context of introgressing large DNA sequences by traditional breeding (Conner &
Jacobs, 1999). However, conventionally introgressed genes are numerous and their
functions remain essentially unknown, whereas transgenes are controlled by their
nature, making them more reliable in terms of obtaining the desired outcome.
CONCLUSIONS
Despite the rapid increase in areas cultivated with GM crops and the widespread
adoption of GM food and feeds, there still remain public concerns about the safety of
GM crops and their potential impact on public health. Although no correlation between
public perceptions and the scientific data available to date has been established, intense
public and scientific debate regarding the safety of GM crops has led to implementing
mandatory risk assessment of novel GM crops. Rather than causing new food safety
problems, food crops developed until now have shown their potential for improving the
nutritional quality of food and feed. Developing more nutritious food by using
transgenic technology may contribute towards reducing the number of undernourished
people in the world; however, policies and strategies aimed at increasing the income of
people living below the poverty line must also be developed. A growing world
population critically needs the effective contribution of science and technology for
increasing the global food supply. Non-scientific disputes concerning GM crops could
result in serious consequences for agricultural policy, food security and world trade. 
Genetic modification through conventional plant breeding is essentially random and
imprecise, taking up to two decades for producing a commercially valuable new
variety. Genetic modification through transgenic technology (which uses molecular
biology tools) is more powerful and precise in achieving the desired goals than
conventional breeding. Crops and foods produced using transgenic technology have
been available on the market for more than a decade and no harmful effects have
been detected to date. Regulatory agencies have adopted the principle of substantial
equivalence to ensure the food safety of GM crops and, to date, no adverse effects
have been presented in animals or humans after consuming GM food crops approved
on the basis of this principle. This does not mean that GM crops are necessarily risk-
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free. In terms of food safety, they must be addressed within the same context of food
crops genetically modified by traditional crossbreeding. There is no food (natural or
genetically modified) which is absolutely free of risk. It has been well-documented that
all technologies bring benefits and risks to the environment and that no technology is
absolutely safe; GM food crops therefore appear to be no more risky for public health
than conventionally-bred crop varieties.
Some expressions of neoliberalisation from the non-GM movement have been identified
during the debate. One such expression is exemplified by current activism’s strong
market focus. Another aspect associated with non-GM activism tactics is the strong
commitment to individual consumer’s rights and power. Emphasising individual
freedom of choice, alternative food activism seems to be working to change the world
by shopping and, as Roff, 2007, states, using the market will not change the way the
market works.
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